These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 24604374)

  • 1. Neuropsychiatric problems due to oseltamivir treatment in H7N9 bird flu.
    Wiwanitkit V
    Arq Neuropsiquiatr; 2014 Feb; 72(2):172. PubMed ID: 24604374
    [No Abstract]   [Full Text] [Related]  

  • 2. H7N9 bird flu: emerging of psychological problem.
    Joob B; Wiwanitkit V
    Arq Neuropsiquiatr; 2014 Mar; 72(3):257. PubMed ID: 24676447
    [No Abstract]   [Full Text] [Related]  

  • 3. Neuropsychiatric concerns related to influenza treatment.
    Vantine M; Falahee ML; Vallerand AH
    Nurse Pract; 2009 Feb; 34(2):40-4. PubMed ID: 19155886
    [No Abstract]   [Full Text] [Related]  

  • 4. Incidence of neuropsychiatric adverse events in influenza patients treated with oseltamivir or no antiviral treatment.
    Smith JR; Sacks S
    Int J Clin Pract; 2009 Apr; 63(4):596-605. PubMed ID: 19335705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oseltamivir- related psychiatric manifestations.
    Guisado-Macías JA; Rodríguez FF; Méndez-Sánchez F; Bolívar-Perálvarez M
    Actas Esp Psiquiatr; 2012; 40(1):46-8. PubMed ID: 22344496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuropsychiatric adverse events and oseltamivir for prophylaxis.
    Jones M; Hama R; Jefferson T; Doshi P
    Drug Saf; 2012 Dec; 35(12):1187-8; author reply 1188-90. PubMed ID: 23137156
    [No Abstract]   [Full Text] [Related]  

  • 7. ABCB1 polymorphisms and neuropsychiatric adverse events in oseltamivir-treated children during influenza H1N1/09 pandemia.
    L'Huillier AG; Ing Lorenzini K; Crisinel PA; Rebsamen MC; Fluss J; Korff CM; Barbe RP; Siegrist CA; Dayer P; Posfay-Barbe KM; Desmeules JA;
    Pharmacogenomics; 2011 Oct; 12(10):1493-501. PubMed ID: 21902503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A/H1N1 flu. Time for case-control studies of NSAIDs and oseltamivir.
    Herxheimer A; Clarke M; Edwards R; Jefferson T; Loke Y
    BMJ; 2009 Jul; 339():b3048. PubMed ID: 19638383
    [No Abstract]   [Full Text] [Related]  

  • 9. Post-marketing assessment of neuropsychiatric adverse events in influenza patients treated with oseltamivir: an updated review.
    Toovey S; Prinssen EP; Rayner CR; Thakrar BT; Dutkowski R; Koerner A; Chu T; Sirzen-Zelenskaya A; Britschgi M; Bansod S; Donner B
    Adv Ther; 2012 Oct; 29(10):826-48. PubMed ID: 23054689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oseltamivir and abnormal behaviors: true or not?
    Yorifuji T; Suzuki E; Tsuda T
    Epidemiology; 2009 Jul; 20(4):619-21. PubMed ID: 19367165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Using oseltamivir (Tamiflu) as a first line treatment for seasonal or pandemic flu.
    Greener M
    Nurs Times; 2009 Sep 1-7; 105(34):22. PubMed ID: 19788111
    [No Abstract]   [Full Text] [Related]  

  • 12. Possible neuropsychiatric reaction to high-dose oseltamivir during acute 2009 H1N1 influenza A infection.
    Nakamura K; Schwartz BS; Lindegårdh N; Keh C; Guglielmo BJ
    Clin Infect Dis; 2010 Apr; 50(7):e47-9. PubMed ID: 20192728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery process, clinical characteristics, and treatment of patients infected with avian influenza virus (H7N9) in Shanghai.
    Sun Y; Shen Y; Lu H
    Chin Med J (Engl); 2014; 127(1):185-6. PubMed ID: 24384446
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical efficacy observation of atomization inhalation combined with oral administration of oseltamivir in 4 cases with H7N9 avian influenza].
    Li Z; Fu XY; Fang XB; Li J; Chen T; Qiu LM; Cai J; Wang WL; Pan ZQ; Zhang Y; Zhou JL
    Zhonghua Yi Xue Za Zhi; 2017 Jun; 97(24):1883-1887. PubMed ID: 28648014
    [No Abstract]   [Full Text] [Related]  

  • 15. Neuropsychiatric events in an adult patient with influenza a (H3N2) treated with oseltamivir (Tamiflu): a case report.
    Chen R; Fang Z; Huang Y
    BMC Infect Dis; 2019 Mar; 19(1):224. PubMed ID: 30832611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of adverse events following oseltamivir treatment in influenza outpatients, Vaccine Safety Datalink Project, 2007-2010.
    Greene SK; Li L; Shay DK; Fry AM; Lee GM; Jacobsen SJ; Baxter R; Irving SA; Jackson ML; Naleway AL; Nordin JD; Narwaney KJ; Lieu TA
    Pharmacoepidemiol Drug Saf; 2013 Apr; 22(4):335-44. PubMed ID: 23129321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oseltamivir treatment for influenza does not increase digestive intolerance in preterm infants.
    Leick-Courtois C; Haÿs S; Basson E; Mory-Thomas N; Boibieux A; Picaud JC
    Acta Paediatr; 2014 Mar; 103(3):e136-7. PubMed ID: 24372794
    [No Abstract]   [Full Text] [Related]  

  • 18. Health outcomes among patients receiving oseltamivir.
    Enger C; Nordstrom BL; Thakrar B; Sacks S; Rothman KJ
    Pharmacoepidemiol Drug Saf; 2004 Apr; 13(4):227-37. PubMed ID: 15255089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The safety of oseltamivir in patients with influenza: analysis of healthcare claims data from six influenza seasons.
    Blumentals WA; Song X
    MedGenMed; 2007 Oct; 9(4):23. PubMed ID: 18311373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oseltamivir: neuropsychiatric disorders.
    Prescrire Int; 2007 Oct; 16(91):200. PubMed ID: 17926837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.